Metoclopramide-induced supersensitivity psychosis

中國醫藥大學機構典藏 China Medical University Repository, Taiwan > 台中附設醫院 > 期刊論文 > Item 310903500/30260

請使用永久網址來引用或連結此文件: http://ir.cmu.edu.tw/ir/handle/310903500/30260

題名:	Metoclopramide-induced supersensitivity psychosis
作者:	Lu, ML;Pan, JJ;Teng, HW;Su, KP;Shen, WW
貢獻者:	附設醫院精神醫學部;Taipei Med Univ, Dept Psychiat, Wan Fang Hosp, Taipei, Taiwan;China Med Coll & Hosp, Dept Psychiat, Taichung, Taiwan
日期:	2002
上傳時間:	2010-09-24 14:52:04 (UTC+8)
出版者:	HARVEY WHITNEY BOOKS CO
摘要:	Objective: To evaluate retrospectively the impact of [F-18]fluorodeoxyglucose positron emission tomography (FDG-PET) on the detection of recurrent breast cancer based on asymptomatically elevated tumor markers levels. Methods: Whole-body FDG-PET was performed in 30 patients with suspected recurrent breast cancer and asymptomatic tumor marker increase but negative or equivocal other imaging modality results. A blood sample was drawn in each case for marker assay (CA 15-3 and CEA) on the same day as the FDG-PET. All of these 30 asymptomatic patients had either CA 15-3 >32 U/ml or CEA >5 ng/ml. The final diagnosis of recurrent breast cancer was established by operation/biopsy histopathological findings or clinical follow-up for >1 year by additional morphological imaging techniques. Results: Among the 30 patients, the final diagnosis of recurrent breast cancer was established in 38 sites in 28 patients. FDG-PET accurately detected 35/38 sites in 25/28 patients with recurrence. The diagnostic sensitivity and accuracy of FDG-PET in patients with suspected recurrent breast cancer and asymptomatically elevated tumor markers were 96 and 90%, respectively. Conclusions: FDG-PET is a useful technique for detecting recurrent breast cancer suspected from asymptomatically elevated tumor markers levels and has an important clinical impact on the management of these patients.
關聯:	ANNALS OF PHARMACOTHERAPY 36(9):1387-1390
顯示於類別:	[台中附設醫院] 期刊論文

文件中的檔案:

沒有與此文件相關的檔案.

在CMUR中所有的資料項目都受到原著作權保護.

TAIR相關文章

資料載入中.....